CEO Speech - Johnny Shan
Cancer has always been one of deadliest diseases for humanity. Today, cancer patients still face the possibility of recurrence after surgery and chemotherapy because their immune system is still imbalanced. As times gone by and medical breakthroughs continue to amaze us, there has been an increasing in demand from cancer patients for alternative and more effective rehabilitation methods. So for the first time ever, we will carry out our newly invented “4D immune plan” to provide cancer patients with a brand new, more effective and personalized plan that’s tailored according to his or her individual health indicators.
As a US China joint venture company, “4D Immune Plan” has been widely recognized and accepted by the international cancer community and publications. Through some early patient testing and feedbacks, we will continue to work and refine our method to benefit more cancer patients across the world.
Parent Company Introduction
ABOUT Immune Therapeutics Inc
Located in Orlando Florida, Immune Therapeutics Inc. is a late stage clinical stage biopharmaceutical company focused on the development and commercialization of our highly innovative immunotherapies. IMUN is a biotechnology company developing T-Activation immunotherapies to achieve immunomodulation in patients with autoimmune and inflammatory disease and cancer and infectious diseases.
Stimulating the body’s immune system remains one of the most promising approaches in the treatment of Cancers, HIV, Autoimmune Diseases, inflammatory conditions and other chronic infectious diseases. The Company’s development approach is designed to commercialize our immunotherapies by providing affordable non-toxic therapies: utilizing existing clinical trial data.
The Company's technology platform is built surrounding two different immunotherapies, Lodonal™ (Low Dose Naltrexone - LDN) and Methionine-Enkephalin (MENK). Both therapies have been decades in the making, over forty clinical trials run by institutions such as the Pennsylvania State University Medical School at Hershey, University of Chicago, State University of New York, and Multiple Sclerosis Center at UCSF.
The consulting firm is addressing a growing market in cancer, where current treatment options such as chemotherapy and radiation are limited or inadequate, by leveraging a novel patented therapy called 4D Immune Plan to meet unmet medical needs and improve the lives of cancer patients in China and around the world.
Our consultants include experts and professors with special expertise in the field of immunology or tumor immunity. These experts have many years of experiences in immune regulation and counseling patients, and they have provided detailed guidance to patients in China and abroad with many of them eventually attain full recovery.
Official WeChat public address
Copyright © 2018 in accordance with the Company Limited No. 12345678 Liao ICP Shenyang website construction：DAXIONG